Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Study of Imaging of Viral Thymidine Kinase Activity in EBV-Associated and KSHV-Associated Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00982449
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:09.128779+00:00
Published At
2018-09-17T00:00:00+00:00
Record Updated At
2018-09-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hodgkin Lymphoma", "Non Hodgkin Lymphoma", "Kaposi\u0027s Sarcoma", "Gastric Cancer", "Nasopharyngeal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-09-17"
protocolSection.identificationModule.nctId
"NCT00982449"
protocolSection.identificationModule.officialTitle
"Study of Imaging of Viral Thymidine Kinase Activity in EBV-Associated and KSHV-Associated Malignancies"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Non Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Kaposi's Sarcoma (protocolSection.conditionsModule.conditions)
  • Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Nasopharyngeal Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.